CEO Doubles Down. RSI Says Oversold.
Mark Baum just dropped $302K on his own stock at $30.20, even as the technicals scream sell across every timeframe. The RSI at 30 confirms oversold conditions, and he's buying right above support at $28.54. Healthcare's been beaten down for months, but insiders on this name have crushed it historically with 83% wins at 90 days. This is his second buy on record, so he knows something the selling pressure doesn't reflect.
The Filing
| Ticker | HROW |
| Company | HARROW, INC. |
| Insider | Mark Baum, CHIEF EXECUTIVE OFFICER |
| Buy amount | $302,000 |
| Filing date | May 15, 2026 |
| Conviction | Interesting · 56/100 |
| Setup type | Contrarian Setup |
Ultimate members received this analysis in real time.